KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcosa (ACA) EBT (2017 - 2025)

Arcosa's EBT history spans 9 years, with the latest figure at $55.2 million for Q4 2025.

  • For Q4 2025, EBT rose 430.77% year-over-year to $55.2 million; the TTM value through Dec 2025 reached $241.3 million, up 85.62%, while the annual FY2025 figure was $241.3 million, 85.62% up from the prior year.
  • EBT for Q4 2025 was $55.2 million at Arcosa, down from $87.1 million in the prior quarter.
  • Across five years, EBT topped out at $199.9 million in Q4 2022 and bottomed at $8.2 million in Q4 2021.
  • The 5-year median for EBT is $44.8 million (2023), against an average of $51.2 million.
  • The largest annual shift saw EBT skyrocketed 2337.8% in 2022 before it crashed 81.74% in 2023.
  • A 5-year view of EBT shows it stood at $8.2 million in 2021, then surged by 2337.8% to $199.9 million in 2022, then plummeted by 81.74% to $36.5 million in 2023, then crashed by 71.51% to $10.4 million in 2024, then surged by 430.77% to $55.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's EBT are $55.2 million (Q4 2025), $87.1 million (Q3 2025), and $69.8 million (Q2 2025).